Alvarez-Frutos L, Barriuso D, Duran M, Infante M, Kroemer G, Palacios-Ramirez R
Front Oncol. 2024; 13:1292046.
PMID: 38169859
PMC: 10758476.
DOI: 10.3389/fonc.2023.1292046.
Chen J, Li Z, Han Z, Kang D, Ma J, Yi Y
BMC Cancer. 2023; 23(1):530.
PMID: 37296414
PMC: 10257329.
DOI: 10.1186/s12885-023-10943-x.
Pauls M, Chia S
Curr Oncol. 2022; 29(7):5139-5149.
PMID: 35877267
PMC: 9325032.
DOI: 10.3390/curroncol29070407.
Garutti M, Griguolo G, Botticelli A, Buzzatti G, De Angelis C, Gerratana L
Cancers (Basel). 2022; 14(8).
PMID: 35454806
PMC: 9029479.
DOI: 10.3390/cancers14081898.
Phan N, Hsu C, Huang C, Tseng L, Chuang E
Front Oncol. 2021; 11:734015.
PMID: 34745954
PMC: 8567097.
DOI: 10.3389/fonc.2021.734015.
Precision treatment exploration of breast cancer based on heterogeneity analysis of lncRNAs at the single-cell level.
Zhang Y, Zhang D, Meng Q, Liu Z, Xie H, Liu L
BMC Cancer. 2021; 21(1):918.
PMID: 34388989
PMC: 8361656.
DOI: 10.1186/s12885-021-08617-7.
I-SPY 2: a Neoadjuvant Adaptive Clinical Trial Designed to Improve Outcomes in High-Risk Breast Cancer.
Wang H, Yee D
Curr Breast Cancer Rep. 2020; 11(4):303-310.
PMID: 33312344
PMC: 7731787.
DOI: 10.1007/s12609-019-00334-2.
Future perspectives of surgical treatment of breast cancer.
Riis M
Ann Med Surg (Lond). 2020; 59:93-95.
PMID: 33005399
PMC: 7509585.
DOI: 10.1016/j.amsu.2020.09.021.
The prevalence of luminal B subtype is higher in older postmenopausal women with ER+/HER2- breast cancer and is associated with inferior outcomes.
Mills M, Liveringhouse C, Lee F, Nanda R, Ahmed K, Washington I
J Geriatr Oncol. 2020; 12(2):219-226.
PMID: 32859560
PMC: 7907245.
DOI: 10.1016/j.jgo.2020.08.007.
Controlling technical variation amongst 6693 patient microarrays of the randomized MINDACT trial.
Jacob L, Witteveen A, Beumer I, Delahaye L, Wehkamp D, van den Akker J
Commun Biol. 2020; 3(1):397.
PMID: 32719399
PMC: 7385160.
DOI: 10.1038/s42003-020-1111-1.
DGM-CM6: A New Model to Predict Distant Recurrence Risk in Operable Endocrine-Responsive Breast Cancer.
Lei L, Wang X, Mo Y, Cheng S, Zhou Y
Front Oncol. 2020; 10:783.
PMID: 32528885
PMC: 7263173.
DOI: 10.3389/fonc.2020.00783.
High Levels of Chromosomal Copy Number Alterations and TP53 Mutations Correlate with Poor Outcome in Younger Breast Cancer Patients.
Kocak A, Heselmeyer-Haddad K, Lischka A, Hirsch D, Fiedler D, Hu Y
Am J Pathol. 2020; 190(8):1643-1656.
PMID: 32416097
PMC: 7397461.
DOI: 10.1016/j.ajpath.2020.04.015.
RNA-seq from archival FFPE breast cancer samples: molecular pathway fidelity and novel discovery.
Pennock N, Jindal S, Horton W, Sun D, Narasimhan J, Carbone L
BMC Med Genomics. 2019; 12(1):195.
PMID: 31856832
PMC: 6924022.
DOI: 10.1186/s12920-019-0643-z.
Multigene expression signatures in early hormone receptor positive HER 2 negative breast cancer.
Ovcaricek T, Takac I, Matos E
Radiol Oncol. 2019; 53(3):285-292.
PMID: 31553709
PMC: 6765159.
DOI: 10.2478/raon-2019-0038.
Cost effectiveness of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in a Middle-Income Country, Turkey: Results of a Prospective Multicenter Study.
Ozmen V, Cakar B, Gokmen E, Ozdogan M, Guler N, Uras C
Eur J Breast Health. 2019; 15(3):183-190.
PMID: 31312795
PMC: 6619785.
DOI: 10.5152/ejbh.2019.4761.
Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis.
Feng Y, Spezia M, Huang S, Yuan C, Zeng Z, Zhang L
Genes Dis. 2018; 5(2):77-106.
PMID: 30258937
PMC: 6147049.
DOI: 10.1016/j.gendis.2018.05.001.
Machine Learning and Radiogenomics: Lessons Learned and Future Directions.
Kang J, Rancati T, Lee S, Oh J, Kerns S, Scott J
Front Oncol. 2018; 8:228.
PMID: 29977864
PMC: 6021505.
DOI: 10.3389/fonc.2018.00228.
Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
Colomer R, Aranda-Lopez I, Albanell J, Garcia-Caballero T, Ciruelos E, Lopez-Garcia M
Clin Transl Oncol. 2017; 20(7):815-826.
PMID: 29273958
PMC: 5996012.
DOI: 10.1007/s12094-017-1800-5.
Statistical Contributions to Bioinformatics: Design, Modeling, Structure Learning, and Integration.
Morris J, Baladandayuthapani V
Stat Modelling. 2017; 17(4-5):245-289.
PMID: 29129969
PMC: 5679480.
DOI: 10.1177/1471082X17698255.
Clinical utility of multigene profiling assays in early-stage breast cancer.
Chang M, Souter L, Kamel-Reid S, Rutherford M, Bedard P, Trudeau M
Curr Oncol. 2017; 24(5):e403-e422.
PMID: 29089811
PMC: 5659165.
DOI: 10.3747/co.24.3595.
